Clinical Trial Update: Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nivolumab versus placebo to prevent recurrence of melanoma after complete resection of stage IIB/C melanoma; study results have been po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Melanoma | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2023-07-27